About Nexcelom Bioscience
Nexcelom Bioscience is a company based in Lawrence (United States) founded in 2003 was acquired by PerkinElmer in May 2021. Nexcelom Bioscience offers products and services including Cellometer Ascend, Cellaca PLX, and ViaStain AOPI. Nexcelom Bioscience operates in a competitive market with competitors including Halo Labs, Spheryx, Biotrack, TACount and Spectradyne, among others.
- Headquarter Lawrence, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nexcelom.com
- Social LinkedIn X Facebook
- Acquired by PerkinElmer (May 2021)
- Legal Name Revvity, Inc.
- InvestorsPerkinElmer
& 1 more
- Acquired byPerkinElmer
(May 2021)
Products & Services of Nexcelom Bioscience
Nexcelom Bioscience offers a comprehensive portfolio of products and services, including Cellometer Ascend, Cellaca PLX, and ViaStain AOPI.
Device for fast and accurate cell counting in research applications
High-throughput system for assessing cell health and viability
Staining solution for cell viability and analysis in assays
Funding Insights of Nexcelom Bioscience
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Nexcelom Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2018 | – | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Nexcelom Bioscience
Nexcelom Bioscience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include PerkinElmer and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | – | ampersandcapital.com | Boston, United States | |
Medical instruments and supplies are manufactured and provided for healthcare. | 1931 | perkinelmer.com | Waltham, United States |
Investor details for Nexcelom Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nexcelom Bioscience
8 people are tracked at Nexcelom Bioscience (1 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
bo lin | Head of Sales | Leadership |
Collin Weber | Senior Sales Specialist | Team |
CAN TAN | Business Development Manager | Team |
Paul Tarpy | Business Development Manager | Team |
Ruwei Li | Business Development Manager 耐细隆生物仪器(上海)有限公司 | Team |
Bethany LeCain | Sales Support | Team |
Sean Rapson | Senior Territory Sales Manager | Team |
Steven Isett | Sales Specialist | Team |
Complete people profiles for Nexcelom Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nexcelom Bioscience
3 dated milestones of Nexcelom Bioscience across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Nexcelom Bioscience is founded.
- Funding First funding round.
- Exit Acquired by PerkinElmer.
Competitors of Nexcelom Bioscience
Nexcelom Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Halo Labs, Spheryx, Biotrack, TACount and Spectradyne, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| halolabs.com | 2010 | Burlingame, United States | $23.7M | – | Developer of subvisible particle analyzer for life science and materials applications | |
| spheryx.solutions | 2014 | New York, United States | $1.78M | – | Analytical instruments company developing instruments for non-destructive, quantitative measurements of suspended particles | |
| biotrack.nl | 2011 | Leeuwarden, Netherlands | – | – | Rapid microbial detection and identification system | |
| tacount.com | 2009 | Herzliya, Israel | $2.5M | – | Specializes in imaging-based technology for microbiological testing. | |
| nanoparticleanalyzer.com | 2013 | Torrance, United States | – | 14 | Nano-particle counters are manufactured for research and biomedical uses. | |
| bioavlee.com | 2014 | Wroclaw, Poland | $536,432 | 3 | Bacteria are identified rapidly using laser diffraction and neural networks. | |
| cellometer.net | 2003 | Lawrence, United States | – | 98 | Specializes in automated cell counting and analysis expertise. | |
| buglab.com | 2003 | Concord, United States | – | – | Offers biomass monitoring solutions for fermentation and microbial applications. | |
| micro-identification.com | 2010 | San Clemente, United States | – | – | Optical devices for rapid microbial identification in samples are manufactured. |
Detailed competitors of Nexcelom Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nexcelom Bioscience
Websites that share an audience with Nexcelom Bioscience (nexcelom.com).
Websites whose visitors overlap most with Nexcelom Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lifetechnologies.com | 100% | – | – | View details | |
| biocompare.com | 99% | 244.1K | #187,636 | View details | |
ricochetscience.com | ricochetscience.com | 78% | – | – | – |
| cellsignal.com | 77% | 488.2K | #114,694 | View details | |
| chemometec.com | 75% | 31.8K | #992,798 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for Nexcelom Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Nexcelom Bioscience
Complete news archive for Nexcelom Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Nexcelom Bioscience
10 companies that operate in the same segment as Nexcelom Bioscience (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nexcelom Bioscience
Nexcelom Bioscience was founded in 2003 and raised its 1st funding round 15 years after it was founded.
Nexcelom Bioscience is headquartered in Lawrence, United States. It is registered at Lawrence, Kansas, United States.
Founded in 2003 and based in Lawrence, United States, operations focus on the biotechnology sector through the development, manufacturing, and marketing of image-based cytometry tools. Products such as the Cellometer automated counters and Celigo imaging cytometer are utilized for cell analysis and viability assessments in both attached and suspension cells. Fluorescent reagents, kits, disposable hemocytometers, counting chambers, and low-adhesion plates are also provided to support cell-based assays.
Nexcelom Bioscience's top competitors include Halo Labs, Spheryx and Spectradyne.
Nexcelom Bioscience offers Cellometer Ascend, Cellaca PLX, and ViaStain AOPI.
Nexcelom Bioscience has 2 investors. Key investors include PerkinElmer, and Ampersand Capital Partners.
Nexcelom Bioscience operates through Revvity, Inc..
Yes. Nexcelom Bioscience was acquired by PerkinElmer in May 2021.